Clinical Trials on Metastatic Nasopharyngeal Carcinoma in Hong Kong
Total 757 results
-
Hoffmann-La RocheCompletedCarcinoma, Hepatocellular | Liver Metastases | Biliary Tract Cancer | Secondary Liver CancerKorea, Republic of, Denmark, Spain, Taiwan, United States, Hong Kong
-
Progen PharmaceuticalsTerminatedCancer | Hepatocellular Carcinoma | Primary Liver Cancer | Liver Cancer | HepatomaHong Kong, Singapore, United States, Australia, Canada, Italy, Malaysia, Spain, Taiwan, Thailand
-
Hoffmann-La RocheCompletedCarcinoma, HepatocellularUnited States, Hong Kong, Taiwan, Singapore
-
Novartis PharmaceuticalsRecruitingCarcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Nasopharyngeal Carcinoma | Carcinoma, Ovarian Epithelial | Mesothelioma | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Anal Cancer | Cutaneous Melanoma | Esophagogastric Cancer | Carcinoma, Thymic | High Microsatellite...Italy, Spain, Singapore, Taiwan, Japan, Germany, Canada, Hong Kong, United States
-
National Cancer Institute (NCI)CompletedRecurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Salivary Gland Squamous Cell Carcinoma | Recurrent Lip and Oral Cavity Squamous Cell Carcinoma | Recurrent Nasopharyngeal Keratinizing Squamous... and other conditionsUnited States, China
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
Rain Oncology IncTerminatedNSCLC Stage IIIB | NSCLC, Recurrent | NRG1 Fusion | EGFR Exon 20 Insertion Mutation | NSCLC, Stage IIIC | NSCLC, Stage IV | HER2-activating Mutation | ERBB FusionUnited States, Canada, Hong Kong
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedLung CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
GlaxoSmithKlineCompletedNeoplasms, MetastasisKorea, Republic of, Hong Kong, Philippines, Singapore
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Hong Kong, Taiwan, Korea, Republic of
-
Daping Hospital and the Research Institute of Surgery...UnknownNasopharyngeal CarcinomaChina
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Radiation Toxicity | Oral Complications of Radiation TherapyUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Korea, Republic of, Taiwan, Thailand
-
Cellxpert Biotechnology Corp.Medigen Biotechnology CorporationTerminatedCancer | Hepatocellular Carcinoma | Liver CancerKorea, Republic of, Taiwan, Hong Kong, China
-
BayerCompletedCarcinoma, HepatocellularHong Kong, Taiwan, Korea, Republic of, Singapore
-
Uppsala UniversityBaylor College of Medicine; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruitingBreast Cancer | Breast Neoplasms | Sentinel Lymph Node | DCISUnited States, Sweden, Hong Kong
-
Zai Lab (Shanghai) Co., Ltd.TerminatedGastric Cancer | Triple Negative Breast Cancer | Endometrial Carcinoma | Biliary Tract CarcinomaChina
-
Novartis PharmaceuticalsCompletedHepatocellular CarcinomaUnited States, Taiwan, Germany, Italy, Hong Kong, Canada, Japan, Spain
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingEpstein-Barr Virus Infection | Stage III Nasopharyngeal Carcinoma | Stage IVA Nasopharyngeal Carcinoma | Stage IVB Nasopharyngeal Carcinoma | Stage II Nasopharyngeal CarcinomaUnited States, Canada, Taiwan, Puerto Rico, Australia, Hong Kong, Singapore, China
-
Eli Lilly and CompanyCompletedHepatocellular CarcinomaChina, Taiwan, Thailand, Korea, Republic of, Hong Kong
-
Yiviva Inc.RecruitingAdvanced Hepatocellular CarcinomaUnited States, Taiwan, China, Hong Kong
-
AstraZenecaTerminated
-
TularikUnknownHepatocellular CarcinomaUnited States, China
-
Arbutus Biopharma CorporationCompletedHepatocellular Carcinoma | Hepatoma | Liver Cancer, Adult | Liver Cell Carcinoma, AdultUnited States, Taiwan, Singapore, China, Canada, Korea, Republic of
-
Hoffmann-La RocheCompletedNon-Small Cell Lung CancerHong Kong, Taiwan, Philippines, China, Thailand, Indonesia, Australia, Korea, Republic of
-
Omega TherapeuticsRecruitingHepatocellular Carcinoma | Solid Tumor | Liver Cancer | Hepatocellular Carcinoma Non-resectable | Hepatocellular Cancer | Hepatocellular Carcinoma Recurrent | Liver, Cancer of, Non-ResectableUnited States, Hong Kong, Korea, Republic of, Singapore, Taiwan
-
Novartis PharmaceuticalsTerminatedColorectal Cancer | Gastrointestinal Stromal Tumors | Non-small Cell Lung Carcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal SCCUnited States, Germany, Spain, Singapore, Australia, Hong Kong, Belgium, Japan, China
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
Dong-A UniversityCompletedMicroinvasive Squamous Cell CarcinomaKorea, Republic of
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
GC Cell CorporationCompletedHepatocellular CarcinomaKorea, Republic of
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.CompletedSecondary HyperparathyroidismChina, Hong Kong, Korea, Republic of, Taiwan
-
Novartis PharmaceuticalsCompletedEsophageal Squamous Cell CarcinomaTaiwan, Spain, Canada, Singapore, Hong Kong, Korea, Republic of, Belgium, United Kingdom, United States
-
Alentis Therapeutics AGRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Hong Kong, Singapore, Spain, Canada, Italy
-
National Cancer Institute (NCI)TerminatedParaganglioma | Metastatic Adrenal Gland Pheochromocytoma | Recurrent Adrenal Gland Pheochromocytoma | Extra-Adrenal ParagangliomaUnited States, Singapore, Hong Kong
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Novartis PharmaceuticalsCompletedAdvanced Hepatocellular CarcinomaTaiwan, Canada, Italy, Korea, Republic of, Hong Kong, Germany, China, France
-
Proacta, IncorporatedTerminatedHepatocellular CarcinomaUnited States, Taiwan, Singapore, Hong Kong
-
BayerTerminatedCarcinoma, Non-Small-Cell LungChina, Taiwan, Singapore, Thailand, Korea, Republic of, India
-
Dong-A UniversityCompletedBowen's DiseaseKorea, Republic of
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingEsophageal Neoplasms | Lymph Node MetastasesNetherlands, United States, Italy, Spain, Sweden, Brazil, Canada, China, Finland, Germany, Greece, Hong Kong, India, Japan
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerChina, Hong Kong, Russian Federation, Singapore
-
Boston Scientific CorporationCompletedPancreatic CarcinomaAustralia, France, Japan, Belgium, Hong Kong, Italy, China, India, United States
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
National Cancer Center, KoreaTerminatedBreast Cancer | Metastatic DiseaseKorea, Republic of